Literature DB >> 21537826

Positive effect of low-dose imatinib mesylate in a patient with nephrogenic systemic fibrosis.

Tina Rask Elmholdt, Michael Pedersen, Bettina Jørgensen, Mette Ramsing, Anne Braae Olesen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21537826     DOI: 10.2340/00015555-1085

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  2 in total

Review 1.  [Cutaneous manifestations in renal diseases].

Authors:  M Schmid-Simbeck; A Udvardi; B Volc-Platzer
Journal:  Hautarzt       Date:  2016-12       Impact factor: 0.751

Review 2.  Dually Efficacious Medicine Against Fibrosis and Cancer.

Authors:  Daohong Chen
Journal:  Med Sci (Basel)       Date:  2019-03-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.